RUA Life Sciences plc (LON:RUA – Get Free Report) traded up 0.7% during mid-day trading on Tuesday . The stock traded as high as GBX 11.70 ($0.16) and last traded at GBX 11.58 ($0.16). 40,094 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 149,335 shares. The stock had previously closed at GBX 11.50 ($0.16).
RUA Life Sciences Trading Up 0.7%
The company has a quick ratio of 7.32, a current ratio of 9.01 and a debt-to-equity ratio of 5.42. The firm has a market cap of £7.19 million, a P/E ratio of -2.70 and a beta of 1.21. The company’s 50 day simple moving average is GBX 11.61 and its 200-day simple moving average is GBX 11.80.
Insiders Place Their Bets
In related news, insider Lachlan Smith purchased 20,228 shares of the firm’s stock in a transaction dated Friday, May 2nd. The stock was purchased at an average price of GBX 12 ($0.16) per share, with a total value of £2,427.36 ($3,280.22). 51.33% of the stock is owned by insiders.
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Recommended Stories
- Five stocks we like better than RUA Life Sciences
- Do ETFs Pay Dividends? What You Need to Know
- 3 Beaten-Down Stocks Trading 50% Below Their 52-Week Highs
- Learn Technical Analysis Skills to Master the Stock Market
- Tesla: Why Analysts Think It Could Jump Another 47%
- What is the Dow Jones Industrial Average (DJIA)?
- Microsoft’s Outlook Brightens as Analysts Boost Bullish Ratings
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.